Showing results (71-80 of 207) with videos related to
Sort By:
Pageof 21
BMC Cancer|February 2, 2013
Genetic polymorphism of the OPG gene associated with breast cancerJasmin Teresa Ney, Ingolf Juhasz-Boess, Frank Gruenhage, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomasXiaoxun Xie, Hans-Heinrich Wacker, Shaoming Huang, et al.Experimental Cell Research|May 10, 2005
Characterization of the human GARP (Golgi associated retrograde protein) complexHeike Liewen, Ivo Meinhold-Heerlein, Vasco Oliveira, et al.Human Gene Therapy|April 27, 2002
Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a modelBoris Kubuschok, Rudolf Schmits, Frank Hartmann, et al.European Journal of Haematology|September 30, 2020
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphomaDominic Kaddu-Mulindwa, Maciej Rosolowski, Marita Ziepert, et al.Blood|December 31, 2005
Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphomaBertram Glass, Marita Kloess, Martin Bentz, et al.Cancer Immunity|December 18, 2003
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2Claudia Wagner, Frank Neumann, Boris Kubuschok, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximabJörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.Journal of Autoimmunity|October 19, 2010
Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspaninLorenz Thurner, Antje Müller, Martine Cérutti, et al.Blood|July 28, 2010
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study GroupNorbert Schmitz, Lorenz Trümper, Marita Ziepert, et al.Pageof 21